Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33069| Title: | Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply. | Austin Authors: | Mårtensson, Johan;Bellomo, Rinaldo | Affiliation: | Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden. Intensive Care Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, 171 76, Stockholm, Sweden. johan.martensson@regionstockholm.se. Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.;Department of Critical Care, Melbourne University, Melbourne, VIC, Australia.;Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia. |
Issue Date: | 8-Jun-2023 | Date: | 2023 | Publication information: | Critical Care (London, England) 2023-06-08; 27(1) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/33069 | DOI: | 10.1186/s13054-023-04513-7 | ORCID: | Journal: | Critical Care (London, England) | Start page: | 225 | PubMed URL: | 37291591 | ISSN: | 1466-609X | Type: | Journal Article | Subjects: | Sodium-Glucose Transporter 2 Inhibitors/pharmacology Sodium-Glucose Transporter 2 Inhibitors/therapeutic use Sepsis/drug therapy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.